SRTA STRATA CRITICAL MEDICAL CLASS A
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 6 analyst firms say about STRATA CRITICAL MEDICAL CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
Recent analyst activity · last 90 days
No analyst report on SRTA from the last 90 days is in our tracked history; the most recent available is from Ladenburg Thalmann on 6 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Yuan Zhi | Buy | 30 Jul 2026 | 8.00 USD |
| Craig-Hallum | Bill Bonello | Buy | 25 Mar 2026 | 8.00 USD |
| Ladenburg Thalmann | Jon R Hickman | Buy | 6 Aug 2026 | 12.75 USD |
| Lake Street Capital Markets | Benjamin Haynor | Buy | 1 May 2026 | 8.00 USD |
| Weiss Ratings | Unnamed analyst | — | 5 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 26 Mar 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.